Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology

Christoph Maack, Michael Lehrke, Johannes Backs, Frank R. Heinzel, Jean-Sebastien Hulot, Nikolaus Marx, Walter J. Paulus, Patrick Rossignol, Heinrich Taegtmeyer, Johann Bauersachs, Antoni Bayes-Genis, Dirk Brutsaert, Heiko Bugger, Kieran Clarke, Francesco Cosentino, Gilles De Keulenaer, Alessandra Dei Cas, Arantxa Gonzalez, Martin Huelsmann, Guido IaccarinoIda Gjervold Lunde, Alexander R. Lyon, Piero Pollesello, Graham Rena, Niels P. Riksen, Giuseppe Rosano, Bart Staels, Linda W. van Laake, Christoph Wanner, Dimitrios Farmakis, Gerasimos Filippatos, Frank Ruschitzka, Petar Seferovic, Rudolf A. de Boer, Stephane Heymans*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

99 Citations (Scopus)
273 Downloads (Pure)
Original languageEnglish
Pages (from-to)4243-+
Number of pages15
JournalEuropean Heart Journal
Volume39
Issue number48
DOIs
Publication statusPublished - 21-Dec-2018

Keywords

  • PRESERVED EJECTION FRACTION
  • COTRANSPORTER 2 INHIBITION
  • IMPROVES CARDIAC-FUNCTION
  • GLUCAGON-LIKE PEPTIDE-1
  • MYOCARDIAL TRIGLYCERIDE CONTENT
  • VENTRICULAR DIASTOLIC FUNCTION
  • CARDIOVASCULAR OUTCOMES
  • DOUBLE-BLIND
  • KETONE-BODIES
  • THIAZOLIDINEDIONE THERAPY

Cite this